Dihexa

Small-molecule angiotensin IV analog

Dihexa is classified as a small-molecule angiotensin IV analog. It appears in the preclinical literature on neurological and synaptogenesis research, where it has been examined in laboratory models. This page is background about the molecule as a research material and is not medical guidance and not intended for human or animal use.

Classification and structure

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small-molecule compound derived from the angiotensin IV peptide framework and modified for greater metabolic stability and lipophilicity. In the literature it is characterized in the context of the hepatocyte growth factor / c-Met system. It is classified as an angiotensin IV analog research compound.

Areas of research

In the scientific literature this compound appears across the following research areas.

• Synaptogenesis research — Investigated in laboratory models of synapse formation and neural connectivity.
• HGF/c-Met signaling — Appears in studies examining the hepatocyte growth factor and c-Met receptor pathway.
• Angiotensin IV analog studies — Featured in work characterizing metabolically stabilized angiotensin IV derivatives.

As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.

Handling and verification

Store the compound cool, dry, and protected from light per standard research-chemical handling practice. Every in-stock lot ships with a verifiable third-party certificate of analysis (COA).